 | Up a level |
Koziolek, M., Beige, J., Wallbach, M., Zenker, D., Henning, G., Halbach, M., Mader, N., Mahfoud, F., Schlieper, G., Schwenger, V., Hausberg, M., Boergel, J., Lodde, M., van der Giet, M., Mueller-Ehmsen, J., Passauer, J., Parmentier, S., Lueders, S., Kraemer, B. K., Buettner, S., Limbourg, F., Jordan, J., Vonend, O., Predel, H. -G. and Reuter, H. (2017). Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection. Recommendations of the BAT consensus group 2017. Internist, 58 (10). S. 1114 - 1124. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Romanski, S., Stamellou, E., Jaraba, J. T., Storz, D., Kraemer, B. K., Hafner, M., Amslinger, S., Schmalz, H. G. and Yard, B. A. (2013). Enzyme-triggered CO-releasing molecules (ET-CORMs): Evaluation of biological activity in relation to their structure. Free Radic. Biol. Med., 65. S. 78 - 89. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1873-4596
Stamellou, E., Romanski, S., Amslinger, S., Hafner, M., Kraemer, B. K., Schmalz, H. G. and Yard, B. A. (2012). Enzyme-Triggered CO-Releasing Molecules (ET-CORMs): Structural Entities that Mediate Restricted Cell Specificity for CO Release. Transplantation, 94 (10). S. 1134 - 1135. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1534-6080
Stamellou, E., Storz, D., Botov, S., Ntasis, E., Wedel, J., Sollazzo, S., Kraemer, B. K., van Son, W., Seelen, M., Schmalz, H. G. 
ORCID: 0000-0003-0489-1827, Schmidt, A., Hafner, M. and Yard, B. A.
(2014).
Different design of enzyme-triggered CO-releasing molecules (ET-CORMs) reveals quantitative differences in biological activities in terms of toxicity and inflammation.
Redox Biol., 2.
S. 739 - 749.
AMSTERDAM:
ELSEVIER.
ISSN 2213-2317